Intraputaminal Infusion of Nerve Growth Factor to Support Adrenal Medullary Autografts in Parkinson's Disease: One-Year Follow-Up of First Clinical Trial

Archives of Neurology

Volumn 48, Issue 4, 1991, Pages 373-381

  Olson, Lars ^a   Backlund, Erik Olof ^a   Ebendal, Ted ^a   Freedman, Robert ^a   Hamberger, Bertil ^b   Hansson, Per ^b   Hoffer, Barry ^c   Lindblom, Ulf ^c   Meyerson, Björn ^d   Strömberg, Ingrid ^d   Sydow, Olle ^e   Seiger, AÅke ^f  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UPPSALA UNIVERSITY   (Sweden)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; LEVODOPA; NERVE GROWTH FACTOR;

ADRENAL MEDULLA; ADULT; ARTICLE; AUTOGRAFT; CASE REPORT; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN;

ADRENAL MEDULLA; CASE REPORT; EVOKED POTENTIALS; FEMALE; HUMAN; HYPERKINESIS; LEVODOPA; MIDDLE AGE; NERVE GROWTH FACTORS; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; PUTAMEN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, AUTOLOGOUS;

EID: 0025853803     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1991.00530160037011     Document Type: Article

References (74)

1. Olson L. Grafting in the mammalian central nervous system: basic science with clinical promise. In: Magistretti P, ed. Discussions in Neurosciences. Geneva, Switzerland: FESN: 1988;5:1-73.
2. Olson L, Backlund E-O, Freed W, et al. Transplantation of monoamine-producing cell systems in oculo and intracranially: experiments in search of a treatment for Parkinson–s disease. Ann N Y Acad Sci. 1985;457:105-126.
3. Freed W, Hoffer B, Olson L, Wyatt R. Transplantation of catecholamine-containing tissues to restore the functional capacity of the damaged nigrostriatal system. In: Sladek J Jr, Gash D, eds. Neural Transplants: Development and Function. New York, NY: Plenum Press; 1984:373-406.
4. Sladek J Jr, Gash D. Nerve-cell grafting in Parkinson–s disease. J Neurosurg. 1988;68:337-351.
5. Lindvall O. Transplantation into the human brain: present status and future possibilities. J Neurol Neurosurg Psychiatry. 1989;126(suppl):39-54.
6. Gash D, Sladek J Jr. Neural transplantation: problems and prospects: Where do we go from here? Brain Res Mol Brain Res. 1989;5:1-7.
7. Perlow MJ. Freed WJ, Hoffer BJ, et al. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science. 1979;204:643-647.
8. Björklund A, Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 1979;177:555-560.
9. Freed W, Morihisa J, Spoor E, et al. Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour. Nature. 1981;292:351-352.
10. Backlund E-O, Granberg PO, Hamberger B, et al. Transplantation of adrenal medullary tissue to striatum in parkinsonism: first clinical trials. J Neurosurg. 1985;62:169-173.
11. Olson L, Backlund E-O. Sedvall G, et al. Intrastriatal chromaffin grafts in experimental and clinical parkinsonism: first impressions. In: Usdin E, Carlsson A, Dahlström A, Engel J, eds. Catecholamines: Part C: Neuropharmacology and Central Nervous System: Therapeutic Aspects. New York, NY: Alan R Liss Inc; 1984:195-201.
12. Lindvall O, Backlund E-O. Farde L, et al. Transplantation in Parkinson–s disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol. 1987;22:457-468.
13. Madrazo I, Drucker-Collín R, Diaz V, et al. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson–s disease. N Engl J Med. 1987;316:831-834.
14. Bakay R. Herring C. Central nervous system grafting in the treatment of parkinsonism. Stereotact Funct Neurosurg. 1989;53:1-20.
15. Goetz CG, Olanow CW, Koller WC, et al. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson–s disease. N Engl J Med. 1989;320:337-341.
16. Lindvall O, Rehncrona S, Gustaavii B. et al. Fetal dopamine-rich mesencephalic grafts in Parkinson–s disease. Lancet. 1988;2:1483-1484.
17. Lindvall O, Rehncrona S, Brundin P, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson–s disease: a detailed account of methodology and a 6-month follow-up. Arch Neurol. 1989;46:615-631.
18. Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson–s disease. Science. 1990;247:575-577.
19. Olson L, Strömberg I, Ebendal T, Seiger A°, Hoffer B. Grafting strategies in Parkinson–s disease: the chromaffin alternative. In: Lindvall 0, ed. Fernström Symposia. Amsterdam, the Netherlands: Elsevier Science Publishers. In press.
20. Strömberg I, Herrera-Marschitz M, Unger-stedt U, Ebendal T, Olson L. Chronic implants of chromaffin tissue into the dopamine-denervated striatum: effects of NGF on graft survival, fiber growth, and rotational behavior. Exp Brain Res. 1985;60:335-349.
21. Strömberg I, Hultgård—Nilsson A, Hedin U. Ebendal T. Fate of intraocular chromaffin cell suspensions: role of initial nerve growth factor support. Cell Tissue Res. 1988;254:487-497.
22. Strömberg I, Ebendal T. Aged adrenal medullary tissue survives intraocular grafting, forms nerve fibers, and responds to NGF. J Neurosci Res. 1989;23:162-171.
23. Hoehn M, Yahr M. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17:427-442.
24. Mobley W, Schenker A, Shooter E. Characterization and isolation of proteolytically modified nerve growth factor. Biochemistry. 1976;15:5543-5552.
25. Ebendal T, Olson L, Seiger A°, Belew M. Nerve growth factors in chick and rat tissues. In: Black I, ed. Cellular and Molecular Biology of Neuronal Development. New York: Plenum Press; 1984:231-242.
26. Chapman C, Banks B, Carstairs J, Pearce F, Vernon C. The preparation of nerve growth factor from the prostate of the guinea-pig and isolation of immunogenically pure material from the mouse submandibular gland. Fed Eur Biochem Soc Lett. 1979;104:341-344.
27. Ebendal T, Olson L, Seiger A°, Hedlund K-O. Nerve growth factors in the rat iris. Nature. 1980;286:25-28.
28. Ebendal T. Use of collagen gels to bioassay nerve growth factor activity. In: Rush R, ed. Nerve Growth Factors. New York, NY: John Wiley & Sons Inc; 1989:81-93.
29. Lärkfors L, Ebendal T. Highly sensitive enzyme immunoassays for β-nerve growth factor. J Immunol Methods. 1987;97:41-47.
30. Hallman H, Farnebo L-O, Hamberger B, Jonsson G. A sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection. Life Sci. 1978;23:1049-1052.
31. Leksell L, Jernberg B. Stereotaxis and tomography: a technical note. Acta Neurochir (Wien). 1980;52:1-7.
32. Backlund E. Stereotactic catheter insertion: a new technique. Neurol Res. 1987;9:147-150.
33. Hamberger B, Telenius-Berg M, Cedermark B, et al. Subtotal adrenalectomy in multiple endocrine neoplasia type 2. Henry Ford Hosp Med J. 1987;35:127-128.
34. Dick M, Guiloff R, Stewart A, et al. Mini-Mental State examination in neurological patients. J Neurol Neurosurg Psychiatry. 1984;47:496-499.
35. Deecke L, Englitz H, Kornhuber H, Schmidt G. Cerebral potentials preceding voluntary movements in patients with bilateral or unilateral parkinsonian akinesia. Prog Clin Neurophysiol. 1977;1:151-163.
36. Dick J, Cantello R, Buruma O, et al. The bereitschafts-potential, L-dopa and Parkinson–s disease. Electroencephalogr Clin Neurophysiol. 1987;66:263-274.
37. Freedman R, Adler L, Gerhardt G, et al. Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull. 1987;13:669-678.
38. Adler L, Waldo M, Freedman R. Neurophysiologic studies of sensory gating in schizophrenia: comparison of auditory and visual responses. Biol Psychiatry. 1985;20:1284-1296.
39. Grizzle J, Starmer C, Koch G. Analysis of categorical data by linear models. Biometrics. 1969;625:489-504.
40. Seber G, Wild C. Nonlinear Regression. New York, NY: John Wiley and Sons Inc; 1989.
41. Angeletti R, Bradshaw R. Nerve growth factor from mouse submaxillary gland: amino acid sequence. Proc Natl Acad Sci USA. 1971;68:2417-2420.
42. Scott J, Selby M, Urdea M, et al. Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature. 1983;302:538-540.
43. Ullrich A, Gray A, Berman C, Coussens L, Dull TJ. Sequence homology of human and mouse β-NGF subunit genes. Cold Spring Harb Symp Quant Biol. 1983;1:435-442.
44. Tischler, DeLellis R, Biales B, et al. Nerve growth factor-induced neurite outgrowth from normal human chromaffin cells. Lab Invest. 1980;43:399-409.
45. Korsching S, Thoenen H. Nerve ǵrowth factor in sympathetic ganglia and corresponding target organs of the rat: correlation with density of sympathetic innervation. Proc Natl Acad Sci USA. 1983;80:3513-3516.
46. Olson L. Fluorescence histochemical evidence for axonal growth and secretion from transplanted adrenal medullary tissue. Histochemie. 1970;22:1-7.
47. Freed WJ, Cannon-Spoor HE, Krauthamer E. Intrastriatal adrenal medulla grafts in rats: long-term survival and behavioral effects. J Neurosurg. 1986;65:664-670.
48. Strömberg I, Ebendal T, Seiger A°, Olson L. Nerve fiber production by intraocular adrenal medullary grafts: stimulation by nerve growth factor or sympathetic denervation of the host iris. Cell Tissue Res. 1985;241:241-249.
49. Whittemore SR, Ebendal T, Lärkfors L, et al. Developmental and regional expression of β-nerve growth factor messenger RNA and protein in the rat central nervous system. Proc Natl Acad Sci USA. 1986;83:817-821.
50. Korsching S, Auburger G, Heumann R, Scott J, Thoenen H. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J. 1985;4:1389-1393.
51. Hurtig H, Joyce J, Sladek J Jr, Trojanowski JQ. Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson–s disease. Ann Neurol. 1989;25:607-614.
52. Landau W. Clinical neuromythology, VII: artificial intelligence: the brain transplant cure for parkinsonism. Neurology. 1990:40:733-740.
53. Sladek J Jr, Redmond D Jr, Collier T, et al. Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. Prog Brain Res. 1988;78:497-506.
54. Hansen J, Kordower J, Fiandaca M, et al. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: graft viability and fine structure. Exp Neurol. 1988;102:65-75.
55. Goetz C, Tanner C, Penn R, et al. Adrenal medullary transplant to the striatum of patients with advanced Parkinson–s disease: 1-year motor and psychomotor data. Neurology. 1990;40:273-276.
56. Lieberman A, Ransohoff J, Berczeller P, et al. Adrenal medullary transplants as a treatment for advanced Parkinson–s disease. Acta Neurol Scand Suppl. 1989;126:189-196.
57. Apuzzo M, Neal J, Water C, et al. Utilization of unilateral and bilateral stereotactically placed adrenomedullary-striatal autografts in parkinsonian humans: rationale, techniques, and observations. Neurosurgery. 1990;26:746-757.
58. Allen G, Burns R, Tulipan N, Parker R. Adrenal medullary transplantation to the caudate nucleus in Parkinson–s disease: initial clinical results in 18 patients. Arch Neurol. 1989;46:487-491.
59. Ahlskog J, Kelly P, van Heerden J, et al. Adrenal medullary transplantation into the brain for treatment of Parkinson–s disease: clinical outcome and neurochemical studies. Mayo Clin Proc. 1990;65:305-328.
60. Kelly P, Ahlskog J, van Heerden J, et al. Adrenal medullary autograft transplantation into the striatum of patients with Parkinson–s disease. Mayo Clin Proc. 1989;64:292-290.
61. Bohn MC, Cupit L, Marciano F, Gash DM. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science. 1987;237:913-916.
62. Fiandaca MS, Kordower JH, Hansen JT, Jiao SS, Gash DM. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration. Exp. Neurol. 1988;102:76-91.
63. Claude P, Parada IM, Gordon KA, D–Amore PA, Wagner JA. Acidic fibroblast growth factor stimulates adrenal chromaffin cells to proliferate and to extend neurites, but is not a long-term survival factor. Neuron. 1988;1:783-790.
64. Stemple DL, Mahanthappa NK, Anderson DJ. Basic FGF induces neuronal differentiation, cell division, and NGF dependence in chromaffin cells: a sequence of events in sympathetic development. Neuron. 1988;1:517-525.
65. Leibrock J, Lottspeich F, Hohn A, et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 1989;341:149-152.
66. Hohn A, Leibrock J, Bailey K, Barde Y-A. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature. 1990;344:339-341.
67. Maisonpierre PC, Belluscio L, Squinto S, et al. Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science. 1990;247:1446-1451.
68. Rosenthal A, Goeddel DV, Nguyen T, et al. Primary structure and biological activity of a novel human neurotrophic factor. Neuron. 1990;4:767-773.
69. Ernfors P, Ibanez CF, Ebendal T, Olson L, Persson H. Molecular cloning and neurotrophic activities of a protein with structural similarities to β-nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci USA. 1990;87:5454-5458.
70. Ayer-LeLievre C, Olson L, Ebendal T, Seiger A°, Persson H. Expression of the β-nerve growth factor gene in hippocampal neurons. Science. 1988;240:1339-1341.
71. Wetmore C, Ernfors P, Persson H, Olson L. Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Exp Neurol. 1990;109:141-152.
72. Ernfors P, Lindefors N, Chan-Palay V, Persson H. Cholinergic neurons of nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer type. Dementia. In press.
73. Goedert MA, Dawbarn D, Whilcock C, Chao M. Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer–s disease. Brain Res Mol Brain Res. 1989;5:1-7.
74. Ebendal T. NGF in CNS: experimental data and clinical implications. Prog Growth Factor Res. 1989;1:143-159.